Micaela Medrano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Micaela Medrano has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Analia Graciela Abraham
Centro de Investigación y Desarrollo en Criotecnología de Alimentos, Facultad de Ciencias Exactas, Universidad Nacional de La Plata – CONICET, La Plata, Argentina
8 shared publications - Nicolas Simonelli
Laboratorio de Alimentos, Salud y Microbiota (LASyM), Instituto Ciencias de la Salud, Universidad Nacional Arturo Jauretche (UNAJ), Av. Calchaquí 6200, Florencio Varela, Buenos Aires, Argentina; Centro de Investigación y Desarrollo en Ciencia y Tecnología de Alimentos (CIDCA), UNLP - CONICET - CIC, 47 and 116, La Plata, Buenos Aires, Argentina
3 shared publications Analía Graciela Abraham
Centro de Investigación y Desarrollo en Ciencia y Tecnología de Alimentos (CIDCA, CONICET-UNLP-CIC), Calle 47 y 116 La Plata, Buenos Aires CP 1900, Argentina
2 shared publications- Geert Huys
Laboratory of Microbiology, Ghent University, Ghent, Belgium
2 shared publications - Kumpei Tanisawa
Faculty of Sport Sciences, Waseda University, Tokorozawa, Saitama, Japan
2 shared publications M.F. Hamet
Centro de Investigación y Desarrollo en Criotecnología de Alimentos (CIDCA), Facultad de Ciencias Exactas, Universidad Nacional de La Plata - CONICET CCT La Plata - CIC, 47 y 116, La Plata, Buenos Aires, Argentina
2 shared publications
Latest Publications
- 17 September 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 570, 110104
Fermentation of brewer's spent yeast β-glucans by human gut microbiota yields short-chain fatty acids with potential in vitro immunomodulatory activity
- 17 September 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 570, 110104
Fermentation of brewer's spent yeast β-glucans by human gut microbiota yields short-chain fatty acids with potential in vitro immunomodulatory activity
- Open Access
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
β-GLUCANS FROM BREWER SPENT YEASTS EXERT in vitro IMMUNOMODULATION via SCFA PRODUCTION BY HUMAN INTESTINAL MICROBIOTA
Yeast β-glucans (YBG) have been associated with beneficial biological effects; however, the origin of this activity remains unclear. To investigate whether these effects are mediated by microbial metabolites, this study evaluated the immunomodulatory capacity of short chain fatty acids (SCFA) produced during YBG fermentation by human intestinal microbiota. Yeast cell wall β-glucans were purified by treatment with NaOH and acetic acid, and FTIR spectroscopy was subsequently used to identify the characteristic functional groups of the polymer. Fermentability was then assessed in vitro using pooled faeces from 4 healthy adults. Gas chromatography analysis of SCFA and branched chain fatty acids (BCFA) production after 24 and 48 h confirmed that β-glucans can be fermented by intestinal microbiota, producing mainly acetic, propionic and butyric acids. Next-generation sequencing analysis revealed that YBG fermentation significantly increased the relative abundance of Selenomonadaceae and Veillonellaceae families. To evaluate the biological relevance of the produced metabolites, SCFA solutions were formulated to mimic the concentrations detected in fermentation supernatants and applied to Caco-2/TC7 human enterocytes exposed to a pro-inflammatory stimulus. These SCFA mixtures effectively modulated the inflammatory response, suggesting that the biological effects associated with YBG fermentation may be mediated, at least in part, by microbiota-derived SCFA. This study integrates, within a single in vitro experimental framework, the human colonic fermentation of YBG, SCFA and BCFA production, intestinal microbiota composition, and immunomodulatory effects. Additionally, these findings support the valorization of brewery by-products as potential functional ingredients in human nutrition.
- 18 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open Accessβ-GLUCANS FROM BREWER SPENT YEASTS EXERT in vitro IMMUNOMODULATION via SCFA PRODUCTION BY HUMAN INTESTINAL MICROBIOTA
Yeast β-glucans (YBG) have been associated with beneficial biological effects; however, the origin of this activity remains unclear. To investigate whether these effects are mediated by microbial metabolites, this study evaluated the immunomodulatory capacity of short chain fatty acids (SCFA) produced during YBG fermentation by human intestinal microbiota. Yeast cell wall β-glucans were purified by treatment with NaOH and acetic acid, and FTIR spectroscopy was subsequently used to identify the characteristic functional groups of the polymer. Fermentability was then assessed in vitro using pooled faeces from 4 healthy adults. Gas chromatography analysis of SCFA and branched chain fatty acids (BCFA) production after 24 and 48 h confirmed that β-glucans can be fermented by intestinal microbiota, producing mainly acetic, propionic and butyric acids. Next-generation sequencing analysis revealed that YBG fermentation significantly increased the relative abundance of Selenomonadaceae and Veillonellaceae families. To evaluate the biological relevance of the produced metabolites, SCFA solutions were formulated to mimic the concentrations detected in fermentation supernatants and applied to Caco-2/TC7 human enterocytes exposed to a pro-inflammatory stimulus. These SCFA mixtures effectively modulated the inflammatory response, suggesting that the biological effects associated with YBG fermentation may be mediated, at least in part, by microbiota-derived SCFA. This study integrates, within a single in vitro experimental framework, the human colonic fermentation of YBG, SCFA and BCFA production, intestinal microbiota composition, and immunomodulatory effects. Additionally, these findings support the valorization of brewery by-products as potential functional ingredients in human nutrition.
- 29 April 2025
- Published by American Chemical Society (ACS) in ACS Food Science & Technology
- Vol. 5 (5) , 1880-1893
Biological Activity of Inulin-Rich Fraction Obtained from Discarded Portions of Regional Cultivated Artichokes (Cynara cardunculus L. var. scolymus)
- 29 April 2025
- Published by American Chemical Society (ACS) in ACS Food Science & Technology
- Vol. 5 (5) , 1880-1893
Biological Activity of Inulin-Rich Fraction Obtained from Discarded Portions of Regional Cultivated Artichokes (Cynara cardunculus L. var. scolymus)
- 22 October 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Stimulation of microbial butyrate synthesis through prebiotics
- 22 October 2024
- Published by Elsevier in Food Bioscience
- Vol. 62
Stimulation of microbial butyrate synthesis through prebiotics
- 11 July 2022
- Published by Elsevier in Food Hydrocolloids
- Vol. 133
β-glucans obtained from beer spent yeasts as functional food grade additive: Focus on biological activity
- 11 July 2022
- Published by Elsevier in Food Hydrocolloids
- Vol. 133
β-glucans obtained from beer spent yeasts as functional food grade additive: Focus on biological activity
- Open Access
- 8 February 2022
- Published by Elsevier in Future Foods
- Vol. 5
Water kefir, a fermented beverage containing probiotic microorganisms: From ancient and artisanal manufacture to industrialized and regulated commercialization
- 8 February 2022
- Published by Elsevier in Future Foods
- Vol. 5
Open AccessWater kefir, a fermented beverage containing probiotic microorganisms: From ancient and artisanal manufacture to industrialized and regulated commercialization
- Open Access
- 1 August 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 170, 52-59
Lactobacillus plantarum CIDCA 8327: An α-glucan producing-strain isolated from kefir grains
- 1 August 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 170, 52-59
Open AccessLactobacillus plantarum CIDCA 8327: An α-glucan producing-strain isolated from kefir grains
- 1 September 2016
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 7 (4) , 585-596
Selected Lactobacillus strains isolated from sugary and milk kefir reduce Salmonella infection of epithelial cells in vitro
The isolation of potentially probiotic strains and the subsequent study of their properties are very important steps to gain insight in the health benefits ascribed to sugary and milk kefir. The aim of the present study was to characterise fifteen Lactobacillus strains isolated from these beverages by determining some surface properties and their ability to antagonise enterocyte cell damage after Salmonella infection in vitro. Lactobacillus surface properties were determined by hydrophobicity, autoaggregation, and coaggregation assays with Salmonella. In addition, lactobacilli adhesion to Caco-2/TC-7 cells and the effect on Salmonella invasion were evaluated. Finally, the disassembly of F-actin cytoskeleton on intestinal epithelial cells was assayed in vitro when Salmonella infection was performed in the presence of selected Lactobacillus strains. Ten out of the 15 strains showed a high adhesion capacity to Caco-2/TC-7 cells. Most of the strains were hydrophilic and non-autoaggregating. Strains isolated from sugary kefir were non-coaggregating with Salmonella, while strains Lactobacillus paracasei CIDCA 83120, 83121, 83123, 83124, 8339, 83102 isolated from milk kefir were able to coaggregate after 1 h. L. paracasei CIDCA 8339 and Lactobacillus kefiri CIDCA 83102 were able to diminish Salmonella invasion to the enterocytes. An antagonistic effect on cytoskeleton disruption elicited by the pathogen was also demonstrated. Our results suggest that both strains isolated from milk kefir could be considered as appropriate probiotic candidates.
- 1 September 2016
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 7 (4) , 585-596
Selected Lactobacillus strains isolated from sugary and milk kefir reduce Salmonella infection of epithelial cells in vitro
The isolation of potentially probiotic strains and the subsequent study of their properties are very important steps to gain insight in the health benefits ascribed to sugary and milk kefir. The aim of the present study was to characterise fifteen Lactobacillus strains isolated from these beverages by determining some surface properties and their ability to antagonise enterocyte cell damage after Salmonella infection in vitro. Lactobacillus surface properties were determined by hydrophobicity, autoaggregation, and coaggregation assays with Salmonella. In addition, lactobacilli adhesion to Caco-2/TC-7 cells and the effect on Salmonella invasion were evaluated. Finally, the disassembly of F-actin cytoskeleton on intestinal epithelial cells was assayed in vitro when Salmonella infection was performed in the presence of selected Lactobacillus strains. Ten out of the 15 strains showed a high adhesion capacity to Caco-2/TC-7 cells. Most of the strains were hydrophilic and non-autoaggregating. Strains isolated from sugary kefir were non-coaggregating with Salmonella, while strains Lactobacillus paracasei CIDCA 83120, 83121, 83123, 83124, 8339, 83102 isolated from milk kefir were able to coaggregate after 1 h. L. paracasei CIDCA 8339 and Lactobacillus kefiri CIDCA 83102 were able to diminish Salmonella invasion to the enterocytes. An antagonistic effect on cytoskeleton disruption elicited by the pathogen was also demonstrated. Our results suggest that both strains isolated from milk kefir could be considered as appropriate probiotic candidates.
- 11 March 2016
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 7 (2) , 237-246
Oral administration of kefiran exerts a bifidogenic effect on BALB/c mice intestinal microbiota
The activity of kefiran, the exopolysaccharide present in kefir grains, was evaluated on intestinal bacterial populations in BALB/c mice. Animals were orally administered with kefiran and Eubacteria, lactobacilli and bifidobacteria populations were monitored in faeces of mice at days 0, 2, 7, 14 and 21. Profiles obtained by Denaturing Gradient Gel Electrophoresis (DGGE) with primers for Eubacteria were compared by principal component analysis and clearly defined clusters, correlating with the time of kefiran consumption, were obtained. Furthermore, profile analysis of PCR products amplified with specific oligonucleotides for bifidobacteria showed an increment in the number of DGGE bands in the groups administered with kefiran. Fluorescent In Situ Hybridisation (FISH) with specific probes for bifidobacteria showed an increment of this population in faeces, in accordance to DGGE results. The bifidobacteria population was also studied on distal colon content after 0, 2 and 7 days of kefiran administration. Analysis of PCR products by DGGE with Eubacteria primers showed an increment in the number and intensity of bands with high GC content of mice administered with kefiran. Sequencing of DGGE bands confirmed that bifidobacteria were one of the bacterial populations modified by kefiran administration. DGGE profiles of PCR amplicons obtained by using Bifidobacterium or Lactobacillus specific primers confirmed that kefiran administration enhances bifidobacteria, however no changes were observed in Lactobacillus populations. The results of the analysis of bifidobacteria populations assessed on different sampling sites in a murine model support the use of this exopolysaccharide as a bifidogenic functional ingredient.
- 11 March 2016
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 7 (2) , 237-246
Oral administration of kefiran exerts a bifidogenic effect on BALB/c mice intestinal microbiota
The activity of kefiran, the exopolysaccharide present in kefir grains, was evaluated on intestinal bacterial populations in BALB/c mice. Animals were orally administered with kefiran and Eubacteria, lactobacilli and bifidobacteria populations were monitored in faeces of mice at days 0, 2, 7, 14 and 21. Profiles obtained by Denaturing Gradient Gel Electrophoresis (DGGE) with primers for Eubacteria were compared by principal component analysis and clearly defined clusters, correlating with the time of kefiran consumption, were obtained. Furthermore, profile analysis of PCR products amplified with specific oligonucleotides for bifidobacteria showed an increment in the number of DGGE bands in the groups administered with kefiran. Fluorescent In Situ Hybridisation (FISH) with specific probes for bifidobacteria showed an increment of this population in faeces, in accordance to DGGE results. The bifidobacteria population was also studied on distal colon content after 0, 2 and 7 days of kefiran administration. Analysis of PCR products by DGGE with Eubacteria primers showed an increment in the number and intensity of bands with high GC content of mice administered with kefiran. Sequencing of DGGE bands confirmed that bifidobacteria were one of the bacterial populations modified by kefiran administration. DGGE profiles of PCR amplicons obtained by using Bifidobacterium or Lactobacillus specific primers confirmed that kefiran administration enhances bifidobacteria, however no changes were observed in Lactobacillus populations. The results of the analysis of bifidobacteria populations assessed on different sampling sites in a murine model support the use of this exopolysaccharide as a bifidogenic functional ingredient.
- 1 December 2013
- Published by Elsevier in Food Microbiology
- Vol. 36 (2) , 327-334
Application of culture-dependent and culture-independent methods for the identification of Lactobacillus kefiranofaciens in microbial consortia present in kefir grains
- 1 December 2013
- Published by Elsevier in Food Microbiology
- Vol. 36 (2) , 327-334
Application of culture-dependent and culture-independent methods for the identification of Lactobacillus kefiranofaciens in microbial consortia present in kefir grains